Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Brochures & Literature

 

 

View Channel

 

Conferences | Events

Bio-Industry leader Dr Louis J Nisbet leads BioCity forward

publication date: Nov 23, 2011
 | 
author/source: Integra Communications Ltd
Louis J Nisbet DSc PhD Chairman of BioCity NottinghamNew Chairman of BioCity Nottingham Louis J Nisbet DSc PhD assumes his position this month amidst significant changes and challenges in the global life sciences sector.

With increasing fragmentation in the drug discovery industry and the dramatic reduction in government-funded support for early-stage firms, BioCity Nottingham is providing office and laboratory facilities, infrastructure support and finance for smaller bioscience companies who are discovering new market opportunities. Dr Nisbet will oversee the expansion of BioCity services to cater for the increasing demand from both UK and international tenants. The recent arrival of former AstraZeneca and Pfizer employees launching new ventures, as well as the rapid growth of several existing tenants, makes the BioCity bioscience cluster an attractive central UK business location.

Marlow-based Dr Nisbet is Venture Partner with Kurma BioFund, Paris, and is a highly regarded health industries professional. His early pharmaceutical career in drug discovery research with Roche, Glaxo and Smith Kline gives him a global insight into the issues surrounding the development and commercialisation of new healthcare products and businesses. He will devote time in Nottingham with fellow Board directors to addressing the specific needs of new life science companies, especially their financing requirements.

Speaking ahead of his first Board meeting as Chairman, Dr Nisbet said: "I believe BioCity's strong reputation puts us in a unique position to respond to the growing demand for highly-specialised facilities, support services and funding. Life science and bioscience companies wanting to grow need early stage venture capital but this is presently scarce.  We will be looking to work with our clients and the large pharmaceutical companies, as well as private investors, to find innovative solutions to facilitate partnerships and financing which suit everyone." 

Dr Glenn Crocker CEO of BioCity says: We are looking forward to working with Louis as BioCity continues to evolve. Under his guidance we will be able to plug any gaps in the provision of incubation facilities and services and further develop the Mobius Life Sciences Fund. His world-wide connections will enable us to continue our collaborations with the US, India and the UK life science community to provide the best possible start for promising new companies."

For more information visit www.biocity.co.uk


 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners